Tyler Dove
By POA from Heather Madsen, CEO on Form D filings for PIPr Therapeutics.
None of these filings names Tyler Dove as an officer or director.
Filing agent · Earliest Form D on file: Nov 2025
Filed Nov 12, 2025
PIPr Therapeutics
Preclinical metalloprotease inhibitor drugs
Biotech, Durham NC
Signed as By POA from Heather Madsen, CEO